Clinical Trial Update: Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update reports results for the combination of sorafenib tosylate and pembrolizumab in advanced or metastatic hepatocellular carcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• Nexavar (Sorafenib)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Advanced Adult Hepatocellular Carcinoma, Child-Pugh Class A | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-05-29